Excentrio Therapeutics Llp - Company Profile

It is a chemicals limited liability partnership based in Bangalore, Karnataka, India, established in 2019.
2019 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Excentrio Therapeutics Llp

Excentrio Therapeutics Llp, a active limited liability partnership, was established on 08 March 2019 in Bangalore, Karnataka, India. Engaging in chemicals and chemical products within the chemicals sector, it holds LLPIN: AAO-4823. Registered under ROC Roc Bangalore. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Ashok Suryachandra Rao Godavarthi (Designated Partner), Nagabharathi Kalagara (Designated Partner). Past directors included Ashok Suryachandra Rao Godavarthi. It is based at Plot No 99 , 8Th Main Road , Iii Phase Peenya Industrial Area, Bangalore, Karnataka, 560058.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAO-4823

  • Incorporation Date

    08 March 2019

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 7 Year, 4 Days
Company report

Excentrio Therapeutics Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Excentrio Therapeutics Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Excentrio Therapeutics Llp?
Current Designated Partners
Name Designation Appointment Date Status
Ashok Suryachandra Rao Godavarthi Designated Partner 29 Nov 2019 Current
Nagabharathi Kalagara Designated Partner 10 Dec 2019 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner 28 Nov 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Excentrio Therapeutics Llp.

Enhance accessibility to Excentrio Therapeutics Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Excentrio Therapeutics Llp revenue growth over time
Excentrio Therapeutics Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Excentrio Therapeutics Llp?

Unlock access to Excentrio Therapeutics Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Excentrio Therapeutics Llp?

Unlock and access historical data on people associated with Excentrio Therapeutics Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Excentrio Therapeutics Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Excentrio Therapeutics Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Excentrio Therapeutics Llp
Recent Activity within the Organization
  • Director Appointment

    Progress on Nagabharathi Kalagara was appointed as a Designated Partner was appointed as a Designated Partner on 10 Dec 2019 & has been associated with this company since 6 years 3 months . was documented.

  • Director Appointment

    Progress on Ashok Suryachandra Rao Godavarthi was appointed as a Designated Partner was appointed as a Designated Partner on 29 Nov 2019 & has been associated with this company since 6 years 3 months . was documented.

  • LLP Incorporation

    Progress on Excentrio Therapeutics Llp was registered on 08 Mar 2019 with Roc Bangalore & aged 7 years 4 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Excentrio Therapeutics Llp?

The LLPIN of Excentrio Therapeutics Llp is AAO-4823.

Where is Excentrio Therapeutics Llp headquartered?

Excentrio Therapeutics Llp is headquartered at Plot No 99 , 8Th Main Road , Iii Phase Peenya Industrial Area, Bangalore, Karnataka, 560058.

When was Excentrio Therapeutics Llp incorporated?

Excentrio Therapeutics Llp was incorporated on 08 March 2019.

Who are the current directors of Excentrio Therapeutics Llp?

The current directors of Excentrio Therapeutics Llp are

What is the primary industry of Excentrio Therapeutics Llp?

The primary industry of Excentrio Therapeutics Llp is Chemicals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available